Dirik Eray, Yiş Uluç, Paşaoğlu Güven, Chambaz Céline, Baumgartner Matthias R
Dokuz Eylül University School of Medicine, Department of Pediatrics, Division of Child Neurology, 35340 Izmir, Turkey.
Brain Dev. 2008 Mar;30(3):218-20. doi: 10.1016/j.braindev.2007.08.005. Epub 2007 Sep 14.
A patient with isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency with an unusual clinical presentation is described. The patient presented with clusters of seizures with two or three months disease free interval in the first year of life which then evolved into attacks of status epilepticus after the age of 12 months. MCC deficiency was suspected because of elevated C5-OH-carnitine in tandem mass spectrometry and elevated 3-hydroxy-isovaleric acid in urine organic acid analysis. Deficiency of MCC was confirmed in cultured fibroblasts and mutation analysis revealed a novel mutation in MCCB, p.S39F. Attacks of status epilepticus as a predominant symptom have not been described before in isolated MCC deficiency.
本文描述了一名患有孤立性3-甲基巴豆酰辅酶A羧化酶(MCC)缺乏症且临床表现异常的患者。该患者在出生后第一年出现癫痫发作群,发作间期有两到三个月无病期,12个月龄后发展为癫痫持续状态发作。由于串联质谱法检测到C5-OH-肉碱升高以及尿有机酸分析显示3-羟基异戊酸升高,怀疑存在MCC缺乏症。在培养的成纤维细胞中证实了MCC缺乏,突变分析显示MCCB基因存在一个新的突变,即p.S39F。以前在孤立性MCC缺乏症中尚未有以癫痫持续状态发作为主要症状的描述。